Cabinet Barny advised Meiogenix on the conclusion of a licence agreement with Bayer, where Meiogenix has granted Bayer a licence on its StiX proprietary technology, in the field of genetic technologies.

Click here for more information.

Cabinet Barny advised Peptimimesis on the conclusion of a research partnership agreement with Ipsen in the field of oncology.

Cabinet Barny advised Enterome on the conclusion of a collaborative research agreement with Johnson & Johnson Innovation for the discovery of novel targets and therapeutics for the treatment of Crohn’s disease.